Ticker >

Ambalal Sarabhai Ent share price

Ambalal Sarabhai Enterprises Ltd.

NSE: AMBASARABH BSE: 500009 SECTOR: Pharmaceuticals & Drugs  21k   65   16

69.06
-0.12 (-0.17%)
BSE: Today, 09:54 AM

Price Summary

Today's High

₹ 70

Today's Low

₹ 68.01

52 Week High

₹ 77.7

52 Week Low

₹ 26.05

FinStar

Ownership Below Par
Stock price may face volatility due to ownership structure.
ValuationExpensive
The stock is at a premium valuation at this point.
EfficiencyPoor
The company seems highly inefficient in case of asset management.
FinancialsVery Stable
The company possesses stable growth history and manageable debt.
*It is just an analytical rating of the company and not an investment advice.

Company Essentials

Market Cap

529.23 Cr.

Enterprise Value

536.24 Cr.

No. of Shares

7.66 Cr.

P/E

204.87

P/B

13.13

Face Value

₹ 10

Div. Yield

0 %

Book Value (TTM)

₹  5.26

CASH

3.01 Cr.

DEBT

10.03 Cr.

Promoter Holding

30.77 %

EPS (TTM)

₹  0.34

Sales Growth

2.8%

ROE

6.61 %

ROCE

5.97%

Profit Growth

-37.16 %

* Total debt includes long term borrowing, short term borrowing plus current maturities of long-term borrowing
* Ratios are based on latest Audited Financial Result.

Your Added Ratios

Please login to Add & View your own added ratios.

Login

Price Chart 1d 1w 1m 3m 6m 1Yr 3Yr 5Yr

 

Volume Chart 1d 1w 1m 3m 6m 1Yr 3Yr 5Yr

* Prices are based on daily market changes.
* The chart is based on the standalone earnings of the company. * Negative values and values more than 1000x in PE chart is considered 0.

Peer Comparison

View Full Peer Comparison
* The Peers list includes companies operating in the same industry and having comparable market cap.

 Group Companies

Track the companies of Group.

Ratios

Sales Growth

1 Year2.8%
3 Year∞%
5 Year∞%

Profit Growth

1 Year-37.16%
3 Year31.52%
5 Year21.66%

ROE%

1 Year6.61%
3 Year9.09%
5 Year9.73%

ROCE %

1 Year5.97%
3 Year8.07%
5 Year8.53%

Debt/Equity

0.2488

Price to Cash Flow

-138.63

Interest Cover Ratio

1.3775

CFO/PAT (5 Yr. Avg.)

0

Share Holding Pattern

Promoter Pledging %

Date Promoter % Pledge %
Jun 2024 30.77 0
Mar 2024 30.77 0
Dec 2023 30.77 0
Sep 2023 30.77 0
Jun 2023 30.77 0
Investors List
* Figures given above are % of equity capital

 Strengths

  • The company has shown a good profit growth of 31.5241929923229% for the Past 3 years.
  • The company has an efficient Cash Conversion Cycle of -1528.4349 days.

 Limitations

  • Company has contingent liabilities of 50.4897 Cr.
  • Company has negative cash flow from operations of -3.8175.
  • Tax rate is low at -217.1516.
  • The company has a low EBITDA margin of -926.264849411764% over the past 5 years.
  • The company is trading at a high PE of 204.87.
  • The company is trading at a high EV/EBITDA of 173.9522.

Quarterly Result (All Figures in Cr.)

PARTICULARS Mar 2023 Jun 2023 Sep 2023 Dec 2023 Mar 2024
Net Sales 0.37 1.7 0.8 0.33 0.99
Total Expenditure 1.67 4.85 2.13 1.95 1.65
Operating Profit -1.3 -3.15 -1.33 -1.63 -0.66
Other Income 3.35 1.18 1.97 1.33 3.42
Interest 0.05 0.03 0.04 0.06 0.07
Depreciation 0.03 0.03 0.03 0.03 0.03
Exceptional Items -0.75 0 0 0 0
Profit Before Tax 1.23 -2.02 0.56 -0.39 2.66
Tax 0.11 0 0 0.27 -2.04
Profit After Tax 1.12 -2.02 0.56 -0.65 4.7
Adjusted EPS (Rs) 0.15 -0.26 0.07 -0.09 0.61

Profit & Loss (All Figures in Cr. Adjusted EPS in Rs.)

PARTICULARS Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024
Net Sales 0 0 0.13 3.71 3.81
Total Expenditure 7.85 38.14 5.69 8.86 8.62
Operating Profit -7.85 -38.14 -5.57 -5.16 -4.8
Other Income 24.61 29.61 39.54 10.53 7.89
Interest 0.46 0.56 0.25 0.11 2.16
Depreciation 0.39 0.38 0.19 0.15 0.12
Exceptional Items 0 0 -30.08 -0.79 0
Profit Before Tax 15.9 -9.47 3.45 4.34 0.81
Tax 0.35 -0.08 0.5 0.23 -1.77
Net Profit 15.55 -9.39 2.96 4.11 2.58
Adjusted EPS (Rs.) 2.03 -1.22 0.39 0.54 0.34

Balance Sheet (All Figures are in Crores.)

Particulars Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024
Equity and Liabilities
Share Capital 76.63 76.63 76.63 76.63 76.63
Total Reserves -36.39 -45.85 -42.93 -38.79 -36.34
Borrowings 0 0.18 0.15 0.11 0.06
Other N/C liabilities 0.2 -0.93 -0.77 -0.94 -0.58
Current liabilities 82.23 67.77 48.42 41.49 40.65
Total Liabilities 122.68 97.81 81.51 78.5 80.42
Assets
Net Block 14.48 13.97 13 12.86 12.84
Capital WIP 0 0 0 0 0
Intangible WIP 0 0 0 0 0
Investments 64.77 34.92 25.54 25.54 25.39
Loans & Advances 0 0.37 0.38 5.7 5.7
Other N/C Assets 0 0 0 0 0
Current Assets 43.43 48.54 42.59 34.4 36.49
Total Assets 122.68 97.81 81.51 78.5 80.42
* Other Non-current Liabilities include Net deferred Liabilities

Cash Flows (All Figures are in Crores.)

PARTICULARS Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024
Profit from operations 15.9 -9.47 3.45 4.34 0.81
Adjustment -21.64 1.54 -1.13 -5.71 -3.98
Changes in Assets & Liabilities 1.69 -2.06 -9.49 3.68 0.02
Tax Paid -0.49 -0.43 -0.63 -0.79 -0.68
Operating Cash Flow -4.53 -10.42 -7.79 1.52 -3.82
Investing Cash Flow 4.92 15.76 20.77 0.61 3.48
Financing Cash Flow -0.42 -0.32 -16.46 -3.76 0.3
Net Cash Flow -0.03 5.02 -3.47 -1.63 -0.04

Corporate Actions

Investors Details

PARTICULARS Jun 2023% Sep 2023% Dec 2023% Mar 2024% Jun 2024%
promoters 30.77 30.77 30.77 30.77 30.77
adana investments pvt.ltd... 0.21 0.21 0.21 0.21 0.21
ashavari investments pvt.... 0.24 0.24 0.24 0.24 0.24
bhadrapad investments pvt... 0.21 0.21 0.21 0.21 0.21
bilawal investments pvt.l... 0.21 0.21 0.21 0.21 0.21
jonpuri investments pvt.l... 0.23 0.23 0.23 0.23 0.23
kanda investments pvt.ltd... 0.27 0.27 0.27 0.27 0.27
kartikeya vikram sarabhai... 0.16 0.16 0.16 0.16 0.16
khamaj investments pvt.lt... 0.21 0.21 0.21 0.21 0.21
koshalya investments pvt ... 0.60 0.60 0.60 0.60 0.60
leena investments pvt ltd... 0.17 0.17 0.17 0.17 0.17
madhavbag holdings pvt.lt... 0.23 0.23 0.23 0.23 0.23
mallika vikram sarabhai 0.17 0.17 0.17 0.17 0.17
medicinal drugs mfg.pvt.l... 0.21 0.21 0.21 0.21 0.21
mohal kartikeya sarabhai 0.07 0.07 0.07 0.07 0.07
mrigank investments pvt.l... 0.23 0.23 0.23 0.23 0.23
rajka designs private lim... 0.22 0.22 0.22 0.22 0.22
sahayog investments pvt.l... 0.21 0.21 0.21 0.21 0.21
samvit kartikeya sarabhai... 0.06 0.06 0.06 0.06 0.06
sarabhai holdings private... 25.19 25.19 25.19 25.19 25.19
sarabhai management corpo... 0.12 0.12 0.12 0.12 0.12
talimi investments pvt.lt... 0.21 0.21 - 0.21 0.21
todirag holdings pvt.ltd.... 0.24 0.24 0.24 0.24 0.24
vaishakhi investments pvt... 0.24 0.24 0.24 0.24 0.24
vasantbahar investments p... 0.26 0.26 0.26 0.26 0.26
yudhisthar investments pv... 0.61 0.61 0.61 0.61 0.61
talimi investments pvt.lt... - - 0.21 - -
PARTICULARS Jun 2023% Sep 2023% Dec 2023% Mar 2024% Jun 2024%
investors 69.23 69.23 69.23 69.23 69.23
haryana containers limite... 1.61 1.61 1.61 1.61 1.61
sharad kanayalal shah - - - - 1.01

Annual Reports

Ratings & Research Reports

No Credit and Research reports exist for this company.Report us

Company Presentations

Currently we do not have any Presentation and Concall related to this company.Report us

Company News

Ambalal Sarabhai Enterprises informs about confirmation certificate4 Jul 2024, 5:23PM Ambalal Sarabhai Enterprises informs about outcome of board meeting24 May 2024, 5:28PM Ambalal Sarabhai Ent - Quaterly Results24 May 2024, 3:48PM Ambalal Sarabhai Ent - Quaterly Results24 May 2024, 3:48PM Ambalal Sarabhai Ent - Quaterly Results24 May 2024, 3:48PM Ambalal Sarabhai Ent - Quaterly Results13 Feb 2024, 7:02PM Ambalal Sarabhai Ent - Quaterly Results13 Feb 2024, 7:02PM Ambalal Sarabhai Enterprises informs about disclosure3 Feb 2024, 2:38PM Ambalal Sarabhai Enterprises informs about resignation letter of CS3 Feb 2024, 12:57PM Ambalal Sarabhai Ent - Quaterly Results7 Nov 2023, 6:01PM Ambalal Sarabhai Ent - Quaterly Results7 Nov 2023, 6:01PM Ambalal Sarabhai Ent - Quaterly Results10 Aug 2023, 5:06PM Ambalal Sarabhai Ent - Quaterly Results10 Aug 2023, 5:06PM Ambalal Sarabhai Enterprises informs about trading window closure1 Jul 2023, 12:24PM Ambalal Sarabhai Enterprises’ arm starts new oncology, synthetic API plant in Vadodara9 Jun 2023, 4:40PM Ambalal Sarabhai Enterprises submits newspaper clippings1 Jun 2023, 5:09PM Ambalal Sarabhai Enterprises informs about disclosure15 May 2023, 2:32PM Ambalal Sarabhai Enterprises informs about certificate18 Apr 2023, 4:26PM Ambalal Sarabhai Ent - Quaterly Results10 Feb 2023, 4:09PM Ambalal Sarabhai Ent - Quaterly Results10 Feb 2023, 4:09PM Ambalal Sarabhai Ent - Quaterly Results10 Feb 2023, 4:09PM Ambalal Sarabhai Ent - Quaterly Results9 Nov 2022, 6:44PM Ambalal Sarabhai Ent - Quaterly Results9 Nov 2022, 6:44PM Ambalal Sarabhai Enterprises informs about compliances-certificate20 Oct 2022, 5:21PM Ambalal Sarabhai Enterprises informs about newspaper advertisements14 Sep 2022, 3:07PM Ambalal Sarabhai Enterprises informs about press release18 Aug 2022, 1:26PM Ambalal Sarabhai Enterprises informs about annual secretarial compliance30 May 2022, 5:23PM Ambalal Sarabhai Enterprises informs about board meeting18 May 2022, 12:32PM Ambalal Sarabhai Enterprises informs about disclosure29 Apr 2022, 2:48PM Ambalal Sarabhai Enterprises informs about compliance certificate 25 Apr 2022, 1:50PM Ambalal Sarabhai’s arm’s JV gets nod to manufacture, sell SARAQ HCV viral load kit21 Apr 2022, 12:15PM Ambalal Sarabhai Enterprises informs about issuance of duplicate share certificates22 Feb 2022, 3:41PM Ambalal Sarabhai Enterprises informs about board meeting5 Feb 2022, 12:47PM Ambalal Sarabhai Enterprises informs about confirmation certificate14 Oct 2021, 3:36PM Ambalal Sarabhai’s JV receives CDSCO license to manufacture SARAGENE Dengue Test Kit17 Sep 2021, 10:38AM Ambalal Sarabhai Enterprises informs about confirmation certificate8 Jul 2021, 2:44PM Ambalal Sarabhai Enterprises informs about declaration of unmodified opinion5 Jun 2021, 3:11PM Ambalal Sarabhai’s JV receives CDSCO license to manufacture CHIKV Test Kit 23 Mar 2021, 10:22AM Ambalal Sarabhai Enterprises gets nod to enter into SPA with Asence Pharma27 Nov 2020, 12:04PM Ambalal Sarabhai Enterprises’ JV gets permission to manufacture COVID-19 test with two target genes27 Nov 2020, 8:58AM Ambalal Sarabhai Enterprises informs about compliance certificate14 Oct 2020, 3:44PM CDSO grants manufacturing license to Ambalal Sarabhai’s arm’s JV for Covid-19 RT-PCR test kits28 Apr 2020, 9:49AM Ambalal Sarabhai Enterprises’ arm’s JV starts import of test kits of Covid-1917 Apr 2020, 9:22AM

Ambalal Sarabhai Ent Stock Price Analysis and Quick Research Report. Is Ambalal Sarabhai Ent an attractive stock to invest in?

The Indian healthcare sector is expected to reach US$ 372 billion by 2022, driven by rising incomes, greater health awareness, lifestyle diseases and increasing access to insurance. Healthcare has become one of India’s largest sectors - both in terms of revenue and employment.

Healthcare comprises hospitals, medical devices, clinical trials, outsourcing, telemedicine, medical tourism, health insurance, and medical equipment. The structure of the healthcare delivery system in India consists of three broad segments: Primary care, Secondary care, and Tertiary care.

  • Primary care is the first point of contact between the population and the healthcare service providers. For example, Sub-center (SC), Primary Health Centre (PHC) and Community Health Centre (CHC) which is more relevant to rural areas (PHC’s).
  • Secondary care providers inpatient as well as outpatient medical services and includes simple surgical procedures. For example, District level & Mid-sized hospitals.
  • Tertiary care is the third level of the healthcare delivery system in the country. These hospitals are specialized consultative healthcare infrastructure. For example, Single specialty and Multi-specialty hospitals.

While healthcare services are offered by the public as well as private sectors, in urban as well as rural areas, generally people prefer private hospitals over public hospitals for treatment of diseases, illness, and sickness. So, let’s look into Ambalal Sarabhai Ent and its performance over the period of time. Ambalal Sarabhai Ent stock price today is Rs 69.1.

  • Operating cash flow ratio: It measures the adequacy of a company’s cash generated from operating activities to pay off short-term financial obligations. Ambalal Sarabhai Ent cash from the operating activity was Rs -3.8175 Cr.
     
  • Financial Strength: Health care organizations usually have high debt loads and low equity capital in their balance sheet. So, Debt to Equity ratio is important to analyze the company’s sustainability. Ambalal Sarabhai Ent has a Debt to Equity ratio of 0.2488 , which is a strong indication for the company.
     
  • EPS growth: Investors should ensure the EPS figure is growing faster than revenue numbers because it indicates company management is increasing the efficiency with which it runs the company. In Ambalal Sarabhai Ent , the EPS growth was -37.1551 % which is bad for the company.
     
  • Operating profit margin: It determines a company's potential earnings. It assesses how well-managed a company with respect to its basic overhead costs and other operating expenses, Ambalal Sarabhai Ent has OPM of -126.09631281984 % which is a bad sign for profitability.
     
  • ROE: Ambalal Sarabhai Ent have a poor ROE of 6.6118 %. ROE is an important financial parameter for hospitals & health care companies because they expand and grow rapidly. Therefore, ROE measures how efficiently a shareholder's fund is used for generating profits.
     
  • Share Price: - The current share price of Ambalal Sarabhai Ent is Rs 69.1. One can use valuation calculators of ticker to know if Ambalal Sarabhai Ent share price is undervalued or overvalued.
Last Updated on:
Brief about Ambalal Sarabhai Ent
X